Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Who Is Making The Drugs?. More details...
CBT 200 Drops 17 Points. More details...
CBT 200 Drops 74 Points. More details...
Biotech Toasts Rate Hike With A Loss. More details...
Biotech Inks A Small Gain. More details...
CBT 200 Closes Day And Q1 With Small Gains. More details...
CBT 200 Gives Up Another 28 Points. More details...
CBT 200 Takes A Tumble. More details...
CBT 200 Drops 44 Points. More details...
CBT 200 Drops 10 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China